- Home
- MRNA vs NVT Comparison
MRNA vs NVT Comparison
Compare MRNA & NVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- NVT
- Stock Information
- Founded
- MRNA 2010
- NVT 1903
- Country
- MRNA United States
- NVT United Kingdom
- Employees
- MRNA N/A
- NVT N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- NVT Industrial Machinery/Components
- Sector
- MRNA Health Care
- NVT Industrials
- Exchange
- MRNA Nasdaq
- NVT Nasdaq
- Market Cap
- MRNA 9.2B
- NVT 18.1B
- IPO Year
- MRNA 2018
- NVT N/A
- Fundamental
- Price
- MRNA $24.76
- NVT $104.68
- Analyst Decision
- MRNA Hold
- NVT Strong Buy
- Analyst Count
- MRNA 15
- NVT 11
- Target Price
- MRNA $36.69
- NVT $103.45
- AVG Volume (30 Days)
- MRNA 12.2M
- NVT 2.4M
- Earning Date
- MRNA 11-06-2025
- NVT 10-31-2025
- Dividend Yield
- MRNA N/A
- NVT 0.77%
- EPS Growth
- MRNA N/A
- NVT 6.36
- EPS
- MRNA N/A
- NVT 3.64
- Revenue
- MRNA $2,232,000,000.00
- NVT $3,578,600,000.00
- Revenue This Year
- MRNA N/A
- NVT $27.44
- Revenue Next Year
- MRNA $10.38
- NVT $12.69
- P/E Ratio
- MRNA N/A
- NVT $28.68
- Revenue Growth
- MRNA N/A
- NVT 21.54
- 52 Week Low
- MRNA $23.04
- NVT $41.71
- 52 Week High
- MRNA $48.92
- NVT $117.52
- Technical
- Relative Strength Index (RSI)
- MRNA 46.32
- NVT 48.76
- Support Level
- MRNA $24.18
- NVT $102.00
- Resistance Level
- MRNA $25.33
- NVT $112.46
- Average True Range (ATR)
- MRNA 1.57
- NVT 4.31
- MACD
- MRNA -0.03
- NVT -1.03
- Stochastic Oscillator
- MRNA 30.03
- NVT 16.88
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About NVT nVent Electric plc
NVent is a leading global provider of electrical connection and protection solutions that touch a broad range of end markets, including infrastructure, industrial, commercial, and residential. NVent designs, manufactures, markets, installs, and services a portfolio of electrical enclosures and electrical fastening solutions. North America accounts for the majority of sales.